Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
Clinical trial NCT01472081 · COMPLETED
Trial details
- NCT number
- NCT01472081
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-09
- Primary completion
- 2016-02-02
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.